2 reports

IT IS HOPED THAT THE INCREASED UNDERSTANDING OF HCC' S PATHOLOGY WILL HELP TO IDENTIFY FURTHER POTENTIAL MOLECULAR TARGETS AS WELL AS HELP DEVELOP BIOMARKERS ABLE TO GUIDE TREATMENT DECISIONS.

  • Hepatitis
  • Pathology
  • World
  • Forecast
  • Onxeo SA
  • Pathology
  • France
  • United States
  • Company
  • Onxeo SA